External validation of the EORTC and NCCN bladder cancer recurrence and progression risk calculators in a U.S. community-based health system
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference31 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
2. Legacy of Edwin Beer: fulguration of papillary bladder tumors;Herr;J Urol,2005
3. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016
4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, 2017.
5. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. On relevant features for the recurrence prediction of urothelial carcinoma of the bladder;International Journal of Medical Informatics;2024-06
2. An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer;Frontiers in Oncology;2023-03-16
3. Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data;Cancers;2023-03-07
4. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models;Bladder Cancer;2022-12-14
5. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT;Health Technology Assessment;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3